Trade Summary

4 days ago, Elkins David V, serving as EVP, CFO at Bristol Myers Squibb Co (BMY), sold 30,000 shares at $61.67 per share, for a total transaction value of $1,850,016.00. Following this transaction, Elkins David V now holds 159,542 shares of BMY.

This sale represents a 16.00% decrease in Elkins David V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026, 1 day after the trade was made.

Bristol Myers Squibb Co operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.